Top Class Actions’s website and social media posts use affiliate links. If you make a purchase using such links, we may receive a commission, but it will not result in any additional charges to you. Please review our Affiliate Link Disclosure for more information.
Two class action lawsuit settlements with AstraZeneca Pharmaceuticals, the maker of Zoladex, have been reached. As a result, if you paid for Zoladex within the past nine years, you may be able to claim up to $400 or more from the AstaZeneca Zoladex class action settlements.
The Zoladex settlements resolve a class action lawsuit, entitled In re: Pharmaceutical Industry Average Wholesale Price Litigation, that alleges AstraZeneca reported false and inflated average wholesale prices (AWPs) for Zoladex, a drug used to treat prostate cancer, advanced breast cancer, endometriosis and uterine fibroids. AWPs are used to set drug prices that are paid by Medicare and its beneficiaries, private health insurers, and consumers making percentage co-payments under private health insurance plans. AstraZeneca denies these allegations, but has created a $10 million Nationwide Settlement fund and a $1.4 million Massachusetts Settlement fund to end litigation.
You are considered a class member of the AstraZeneca Zoladex class action settlements if you made a cash or percentage co-payment for Zoladex during the period from January 1, 1991 through June 11, 2010. A “cash payment” is a payment for the full cost of the drug without the help of payment by the insurer or other source, and a “percentage co-payment” is one that varies with the cost of the drug (e.g., 10% or 20% of the cost of the drug). You are not considered a class member if you meet any of the following requirements:
(1) You made flat co-payments (e.g., a flat amount of $10 or $25 per prescription, regardless of the cost of the drug);
(2) Insurance paid all of your co-payment;
(3) Your percentage co-payment was through Medicare Part B; or
(4) You were never obligated to make a co-payment at all.
There are two different settlement classes you can make claims under. The Nationwide Zoladex Settlement class includes all U.S. citizens who purchased Zoladex outside the Commonwealth of Massachusetts during the period from January 1, 1991 through June 11, 2010. The Massachusetts Zoladex Settlement includes all U.S. citizens who purchased Zoladex in Massachusetts during this same period. You may be included in one or both of the Zoladex settlements, depending on where and when you purchased Zoladex.
As a class member of the AstraZeneca Zoladex settlement class, you have two options to get a payment:
(1) Easy Refund Option: Sign a claim form under penalty of perjury stating that you paid cash or a percentage co-payment for Zoladex during the class period and you will be entitled to a one-time payment of up to $400, depending on how many consumers file valid claims.
(2) Full Estimated Refund Option: If you can provide documentation showing the total amount you spent on cash payments or percentage co-payments for Zoladex during the class period, and you can receive a maximum refund of the total amount you spent. This amount may vary, depending on how many class members make successful claims.
All claim forms must be postmarked by February 15, 2011. For claims during the years 1997 through 2004, you may be able to receive up to three time your out-of-pocket expenses for Zoladex. Download your claim form now at the Settlement Administrator’s website at www.AstraZenecaSettlement.com.
See our detailed breakdown of how to file a valid claim for your cash refund from the AstraZeneca Zoladex Class Action Lawsuit Settlement in our Open Lawsuit Settlements section.
Updated November 23rd, 2010
All class action and lawsuit news updates are listed in the Lawsuit News section of Top Class Actions
Top Class Actions Legal Statement
One thought on AstraZeneca Zoladex Class Action Settlement
Prescribed Zoladex in 2010 for treatment of prostate cancer which resulted in two heart attacks…underwent angioplasty surgery and had a stent to open blocked arteries.